PHOX BIOT26 Stock Nasdaq
Equities
PBAXU
US71902K2042
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 68.71M 93.82M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -2M -2.73M | EV / Sales 2022 | - |
Net Debt 2022 | 174K 238K | Net Debt 2023 | 1.46M 1.99M | EV / Sales 2023 | - |
P/E ratio 2022 |
-346
x | P/E ratio 2023 |
-28.3
x | Employees | 9 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 48.77% |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |